3005697
print

Hereditary Gastrointestinal Cancer High-Risk Panel, Sequencing and Deletion/Duplication

GIHR NGS
Example Reports
Negative
Positive

Icon

Hereditary Cancer Testing Patient History Form

Icon

Additional Technical Information

Ordering Recommendation

Germline analysis of genes associated with high-risk hereditary colorectal cancer syndromes, including Lynch syndrome, familial adenomatous polyposis (FAP) or another APC-associated polyposis condition, and MUTYH-associated polyposis (MAP). Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141.

To compare this test to other hereditary cancer panels, refer to the Hereditary Cancer Panel Comparison table.

New York DOH Approval Status

Testing is not New York state approved. Specimens from New York clients will be sent out to a New York state-approved laboratory.

Specimen Required

Patient Preparation
Collect

Lavender or pink (EDTA) or yellow (ACD solution A or B).
New York State Clients: Lavender (EDTA)

Specimen Preparation

Transport 3 mL whole blood. (Min: 2 mL)
New York State Clients: 5 mL (Min: 2 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Serum or plasma; grossly hemolyzed or frozen specimens; saliva, buccal brush, or swab; FFPE tissue; DNA.

Remarks
Stability

Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable
New York State Clients: Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Unacceptable

Methodology

Massively Parallel Sequencing/Sequencing/Multiplex Ligation-dependent Probe Amplification

Performed

Varies

Reported

14-21 days

Reference Interval

By report

Interpretive Data

Refer to report.   

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.

Counseling and informed consent are recommended for genetic testing. Consent forms are available online.

Compliance Category

Laboratory Developed Test (LDT)

Note

Genes Tested: APC*; EPCAM**; MLH1; MSH2; MSH6; MUTYH; PMS2

*One or more exons are not covered by sequencing and/or deletion/duplication analysis for the indicated gene; see Additional Technical Information.
**Deletion/duplication analysis of EPCAM (NM_002354) exon 9 only, sequencing is not available for this gene.

Hotline History

View Hotline History

 

Hotline History

Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
11/14/2022
X
N/A

CPT Codes

81201; 81203; 81292; 81294; 81295; 81297; 81298; 81300; 81406; 81317; 81319; 81479

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
3005698 GIHR Specimen 31208-2
3005699 GIHR Interp 50398-7
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Constitutional mismatch repair deficiency (CMMRD)
  • Gardner syndrome
  • Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS)
  • Hereditary non-polyposis colorectal cancer (HNPCC)
  • Muir-Torre syndrome
  • MYH
  • Turcot syndrome
Hereditary Gastrointestinal Cancer High-Risk Panel, Sequencing and Deletion/Duplication